Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_assertion type Assertion NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_head.
- NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_assertion description "[These results indicate that the F3.Akt1 human NSCs should be a great value as a cellular source for the cellular therapy in animal models of human neurological disorders including ICH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_provenance.
- NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_assertion evidence source_evidence_literature NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_provenance.
- NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_assertion SIO_000772 19440551 NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_provenance.
- NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_assertion wasDerivedFrom befree-20150227 NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_provenance.
- NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_assertion wasGeneratedBy ECO_0000203 NP232174.RA97AJuzocs091cx8WL2juZoZcSFLQOV9Ag6WyNcD2cwM130_provenance.